Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
123.54
-16.97 (-12.08%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 80, with a low estimate of 60 and a high estimate of 100. The average target predicts a decrease of -35.24% from the current stock price of 123.54.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $100 | Strong Buy | Maintains | $75 → $100 | -19.05% | Apr 8, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | -39.29% | Feb 13, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | -59.53% | Nov 12, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | -51.43% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | -63.57% | Sep 18, 2024 |
Financial Forecast
Revenue This Year
418.73M
from 479.95M
Decreased by -12.76%
Revenue Next Year
473.31M
from 418.73M
Increased by 13.03%
EPS This Year
4.15
from 9.71
Decreased by -57.28%
EPS Next Year
4.55
from 4.15
Increased by 9.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 575.5M | 585.3M |
| Avg | 418.7M | 473.3M |
| Low | 330.4M | 363.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 19.9% | 39.8% |
| Avg | -12.8% | 13.0% |
| Low | -31.2% | -13.2% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 11.13 | 8.42 |
| Avg | 4.15 | 4.55 |
| Low | 0.25 | 0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 14.6% | 103.0% |
| Avg | -57.3% | 9.7% |
| Low | -97.5% | -78.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.